CHINA Results of clinical trials of Remdesivir to be published on April 27: NIPA

CHINA

Results of clinical trials of Remdesivir to be published on April 27: NIPA

People's Daily app

15:01, February 25, 2020

微信图片_20200225145914.jpg

Photo: People's Daily

Clinical trials of Remdesivir have been conducted in several hospitals in Wuhan, and the results will be published on April 27, said He Zhimin, the deputy director of the National Intellectual Property Administration (NIPA) at a press conference of the joint prevention and control mechanism of the China’s State Council on Tuesday.

The antiviral drug hasn’t been approved for listing in any country in the world. Gilead Sciences has applied for 8 patents on Remdesivir-related drugs in China, of which 3 have been authorized and 5 are under review, covering chemical compounds, preparations, production methods and uses.

"We are concerned about the effectiveness and safety of Remdesivir and looking forward to see more effective antiviral drug," He said.

At the press conference, officials also introduced measures to maintain market order and support work resumption.

(Compiled by Yang Fan)

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue